Technical Analysis for EDIT - Editas Medicine, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 6.00 | 5.63% | 0.32 |
EDIT closed up 5.63 percent on Wednesday, May 15, 2024, on 1.29 times normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 5.63% | |
| Bollinger Band Squeeze | Range Contraction | 5.63% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 14 hours ago |
| 2x Volume Pace | about 17 hours ago |
| 1.5x Volume Pace | about 17 hours ago |
| 3x Volume Pace | about 17 hours ago |
| Gap Up Partially Closed | about 17 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/03/2024
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome DNA CRISPR Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.9 |
| 52 Week Low | 4.91 |
| Average Volume | 1,894,758 |
| 200-Day Moving Average | 8.11 |
| 50-Day Moving Average | 6.66 |
| 20-Day Moving Average | 5.50 |
| 10-Day Moving Average | 5.59 |
| Average True Range | 0.46 |
| RSI (14) | 52.15 |
| ADX | 21.93 |
| +DI | 29.29 |
| -DI | 18.84 |
| Chandelier Exit (Long, 3 ATRs) | 5.30 |
| Chandelier Exit (Short, 3 ATRs) | 6.30 |
| Upper Bollinger Bands | 5.93 |
| Lower Bollinger Band | 5.07 |
| Percent B (%b) | 1.08 |
| BandWidth | 15.68 |
| MACD Line | -0.24 |
| MACD Signal Line | -0.37 |
| MACD Histogram | 0.1326 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.16 | ||||
| Resistance 3 (R3) | 7.26 | 6.98 | 6.97 | ||
| Resistance 2 (R2) | 6.98 | 6.68 | 6.93 | 6.90 | |
| Resistance 1 (R1) | 6.49 | 6.50 | 6.35 | 6.39 | 6.84 |
| Pivot Point | 6.20 | 6.20 | 6.13 | 6.15 | 6.20 |
| Support 1 (S1) | 5.71 | 5.91 | 5.57 | 5.61 | 5.16 |
| Support 2 (S2) | 5.43 | 5.72 | 5.38 | 5.10 | |
| Support 3 (S3) | 4.94 | 5.43 | 5.03 | ||
| Support 4 (S4) | 4.84 |
